Concepedia

Shumei Liu

SL

Statistics

Publications

31

Citations

3.9K

H-Index

23

Active since

2001

Affiliations

Novartis (United States)(Current)

Harvard University

Liaocheng People's Hospital

Tulane University

Jilin University

Shumei Liu is an author at Novartis (United States) specializing in life sciences, molecular biology, and infectious diseases.

ORCID

Publications per year

2001–2024

31

Publications

31

Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases

Ying-Nan P. Chen, Matthew J. LaMarche, Ho Man Chan et al. · Nature · 2016 · 929 citations

, , +16

Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi Screening

E. Robert McDonald, Antoine de Weck, Michael R. Schlabach et al. · Cell · 2017 · 701 citations · Full text

, , +17

Endogenous angiogenin in endothelial cells is a general requirement for cell proliferation and angiogenesis

Koji Kishimoto, Shumei Liu, Takanori Tsuji et al. · Oncogene · 2004 · 309 citations

, , +7

Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase Inhibitor

Jorge Fortanet, Christine Hiu-Tung Chen, Ying-Nan P. Chen et al. · Journal of Medicinal Chemistry · 2016 · 291 citations · Full text

, , +17

Mutations in a Novel CLN6-Encoded Transmembrane Protein Cause Variant Neuronal Ceroid Lipofuscinosis in Man and Mouse

Hanlin Gao, Rose-Mary N. Boustany, Janice A. Espinola et al. · The American Journal of Human Genetics · 2002 · 223 citations · Full text

, , +4

1–5 of 31